Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -802,00 | 34,87k | Derivative Exercise and Sale | 58,22 | 28,68k | - |
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 571,00 | 0,00 | Derivative Exercise and Retained Stock | - | 28,68k | 2,03% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 1,62k | 0,00 | Derivative Exercise and Retained Stock | - | 27,35k | 6,28% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -1,69k | 104,45k | Derivative Exercise and Sale | 61,73 | 27,35k | - |
| 2026-04-01 | Mr. David V. ElkinsExec. VP & CFO | -30,00k | 1,85M | Automatic Disposition | 61,60 - 62,05 | 159,54k | -15,83% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 2,25k | 0,00 | Derivative Exercise and Retained Stock | - | 7,92k | 39,65% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -3,64k | 76,67k | Derivative Exercise and Sale | 60,13 | 7,92k | - |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 7,41k | 0,00 | Derivative Exercise and Retained Stock | - | 25,55k | 40,83% |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -18,09k | 466,61k | Derivative Exercise and Sale | 60,13 | 25,55k | - |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | 5,69k | 0,00 | Derivative Exercise and Retained Stock | - | 24,75k | 29,84% |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | -11,81k | 272,69k | Derivative Exercise and Sale | 60,13 | 24,75k | - |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 8,93k | 0,00 | Derivative Exercise and Retained Stock | - | 30,36k | 41,69% |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -16,96k | 395,78k | Derivative Exercise and Sale | 60,13 | 30,36k | - |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 6,70k | 0,00 | Derivative Exercise and Retained Stock | - | 27,91k | 31,56% |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -17,38k | 421,81k | Derivative Exercise and Sale | 60,13 | 27,91k | - |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | 2,40k | 0,00 | Derivative Exercise and Retained Stock | - | 17,36k | 16,00% |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | -3,80k | 81,66k | Derivative Exercise and Sale | 60,13 | 17,36k | - |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | 3,50k | 0,00 | Derivative Exercise and Retained Stock | - | 8,21k | 74,27% |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | -4,69k | 83,64k | Derivative Exercise and Sale | 60,13 | 8,21k | - |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2,07k | 0,00 | Derivative Exercise and Retained Stock | - | 13,13k | 18,66% |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -4,92k | 130,18k | Derivative Exercise and Sale | 60,13 | 13,13k | - |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | 1,90k | 0,00 | Derivative Exercise and Retained Stock | - | 7,32k | 35,03% |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | -4,54k | 119,78k | Derivative Exercise and Sale | 60,13 | 7,32k | - |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | 20,27k | 0,00 | Derivative Exercise and Retained Stock | - | 146,89k | 16,01% |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | -51,27k | 1,28M | Derivative Exercise and Sale | 60,13 | 146,89k | - |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | 21,87k | 0,00 | Derivative Exercise and Retained Stock | - | 189,54k | 13,04% |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | -41,11k | 968,93k | Derivative Exercise and Sale | 60,13 | 189,54k | - |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 16,67k | 10,72% |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | -1,67k | 104,28k | Derivative Exercise and Sale | 62,37 | 16,67k | - |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 21,43k | 8,67% |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -833,00 | 45,86k | Derivative Exercise and Sale | 55,05 | 21,43k | - |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | 6,27k | 0,00 | Derivative Exercise and Retained Stock | - | 15,06k | 71,33% |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | -3,81k | 209,74k | Derivative Exercise and Sale | 55,05 | 15,06k | - |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | 1,18k | 0,00 | Derivative Exercise and Retained Stock | - | 126,62k | 0,94% |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | -1,78k | 57,03k | Derivative Exercise and Sale | 46,07 | 126,62k | - |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 3,62k | 0,00 | Derivative Exercise and Retained Stock | - | 19,72k | 22,46% |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -2,67k | 122,78k | Derivative Exercise and Sale | 46,07 | 19,72k | - |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 18,14k | 20,35% |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -3,21k | 148,02k | Derivative Exercise and Sale | 46,07 | 18,14k | - |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2,23k | 0,00 | Derivative Exercise and Retained Stock | - | 11,07k | 25,18% |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -2,33k | 106,64k | Derivative Exercise and Sale | 45,73 | 11,07k | - |
| 2025-09-02 | Mr. David V. ElkinsExec. VP & CFO | -56,00k | 2,65M | Automatic Disposition | 47,33 | 167,66k | -25,04% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 603,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,67k | 11,90% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -632,00 | 29,82k | Derivative Exercise and Sale | 47,18 | 5,67k | - |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 518,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,84k | 6,22% |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -543,00 | 24,02k | Derivative Exercise and Sale | 44,23 | 8,84k | - |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 360,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,07k | 7,65% |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -378,00 | 16,72k | Derivative Exercise and Sale | 44,23 | 5,07k | - |
| 2025-06-13 | Dr. Christopher S. BoernerCEO & Chairman | -62,72k | 0,00 | Other Disposition | - | 125,44k | -33,33% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
